Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Active, not recruiting NASH Cirrhosis, Liver Drug: Resmetirom Drug: Placebo A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide (AMAZE 7) The purpose of this study is to find out if zenagamtide is safe and effective for treating participants who have excess body weight compared to treat
GLP-1 Therapy: Advanced Healthcare GLP-1 therapy represents a significant advancement in the treatment of Type 2 diabetes and obesity
Prescription fees are generally non-refundable after approval
A phase 3 trial found that high-dose oral semaglutide (50 mg) produced a 12.7% placebo-adjusted weight loss at week 68, comparable to subcutaneous semaglutide in patients without diabetes
US$ 29.61
US$ 22.72
US$ 28.64
